HomeNANO • EPA
add
Nanobiotix SA
Nakaraang pagsara
€3.27
Sakop ng araw
€3.26 - €3.33
Sakop ng taon
€2.67 - €7.93
Market cap
155.82M EUR
Average na Volume
97.89K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.64M | 182.08% |
Gastos sa pagpapatakbo | 16.41M | 14.48% |
Net na kita | -10.94M | 22.16% |
Net profit margin | -235.46 | 72.41% |
Kita sa bawat share | — | — |
EBITDA | -11.62M | 5.65% |
Aktuwal na % ng binabayarang buwis | -0.66% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 66.34M | 206.69% |
Kabuuang asset | 86.68M | 114.52% |
Kabuuang sagutin | 108.46M | 15.15% |
Kabuuang equity | -21.78M | — |
Natitirang share | 47.40M | — |
Presyo para makapag-book | -7.11 | — |
Return on assets | -33.93% | — |
Return on capital | -107.38% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -10.94M | 22.16% |
Cash mula sa mga operasyon | -2.92M | 66.22% |
Cash mula sa pag-invest | -250.00K | -52.91% |
Cash mula sa financing | -1.33M | -24.18% |
Net change in cash | -4.47M | 54.71% |
Malayang cash flow | -7.44M | 9.68% |
Tungkol
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
CEO
Itinatag
2003
Website
Mga Empleyado
110
